Figure 3 | Scientific Reports

Figure 3

From: Cardiovascular outcomes of type 2 diabetic patients treated with DPP‑4 inhibitors versus sulphonylureas as add-on to metformin in clinical practice

Figure 3

Subgroup analysis. Adjusted hazard ratios on MACE, comparing Sulphonylureas and DPP-4i cohorts by groups considering history of MACE, age, socio-economic status (SES), body mass index (BMI), HbA1c, several mental illness (SMI) and chronic kidney disease (CKD). Event rates are reported as number of events/1000 person-year.

Back to article page